Trade

Eiko Lifesciences share price

Balanced risk
  • 38%Low risk
  • 38%Moderate risk
  • 38%Balanced risk
  • 38%High risk
  • 38%Extreme risk
  • 51.59(-0.39%)
    June 12, 2026 15:40:01 PM IST
    • NSE
    • BSE
  • Vol : 12.84 K (NSE + BSE)
    Last 20 day avg : 20.38 K

Eiko Lifesciences is trading -0.39% lower at Rs 51.59 as compared to its last closing price. Eiko Lifesciences has been trading in the price range of 53.00 & 50.51. Eiko Lifesciences has given -5.92% in this year & 3.75% in the last 5 days. The company posted a net profit of 1.30 Crores in its last quarter.Listed peers of Eiko Lifesciences include Asian Paints (2.06%), Pidilite Industries (1.91%), Solar Industries India (-0.03%).The Mutual Fund holding in Eiko Lifesciences was at -% in . The MF holding has - from the last quarter. The FII holding in Eiko Lifesciences was at -% in . The FII holding has - from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Jun 13, 2026, 12:41 AM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    -0.72
    Low volatility
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    0.28
    Indicates undervaluation
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    -
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    -
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    -
Price range
Day Range
Lowest
50.51
Highest
53.00
52 week range
Lowest
45.90
Highest
65.90
Eiko Lifesciences Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Asian Paints
Bullish
2,746.502.062,64,032.3864.0212.960.967.13
Pidilite Industries
Bullish
1,527.501.911,55,314.9361.5413.940.672.03
Solar Industries India
Neutral
17,141.85-0.031,54,735.43120.4734.380.069.52
SRF
Moderately Bullish
2,708.601.8780,469.7042.525.760.3314.26
Linde India
Neutral
6,928.003.2559,128.53140.0116.550.061.06
Eiko Lifesciences Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2026-05-26Audited Results
2026-01-29Quarterly Results
2025-12-11Others
2025-10-31Quarterly Results
2025-07-29Quarterly Results
About the company Eiko Lifesciences
  • IndustryChemical Manufacturing
  • ISININE666Q01016
  • BSE Code540204
  • NSE Code
Eiko LifeSciences Limited is an India-based company engaged in manufacturing, processing, formulating, producing, buying, selling, and exporting specialty and fine chemicals. It operates in the Specialty & Fine Chemicals segment. It offers products in Specialty Chemicals and Intermediates, Application Programming Interfaces (APIs), Agrochemical Intermediates, Flavor & Fragrances, and Cosmetic Emollients. Specialty Chemicals and Intermediates include Lasamide, Trichloro Salicylic acid, Chloroacetyl Xylidide and Thiodipropionic acid. Agrochemical Intermediates include 5-chloro-8-hydroxyquinoline. Cosmetic Emollients include Isopropyl Oleate, Isopropyl Laurate, Isopropyl Palmitate, Isopropyl Myristate, Methyl Myristate, Butyl Oleate, Butyl Laurate, and Methyl Myristate, among others. APIs include Topiramate Indian Pharmacopoeia (IP), (United States Pharmacopeia) USP/ European Pharmacopeia (EP), and Glucosamine hydrochloride (HCL)/Sodium/Potassium USP/EP, among others.
  • Management Info
  • Jaid KojarChief Financial Officer
  • Chintan DoshiCompliance Officer, Company Secretary
  • Sumukh VartakAdditional Whole Time Director
Eiko Lifesciences Share Price FAQs

Eiko Lifesciences is trading at 51.59 as on Fri Jun 12 2026 10:10:01. This is -0.39% lower as compared to its previous closing price of 51.79.

The market capitalization of Eiko Lifesciences is 73.73 Cr as on Fri Jun 12 2026 10:10:01.

The 52 wk high for Eiko Lifesciences is 65.90 whereas the 52 wk low is 45.90

Eiko Lifesciences can be analyzed on the following key metrics -

  • TTM P/E: 15.30
  • Sector P/E: -
  • Dividend Yield: 0.00%
  • D/E ratio: 0.07

Eiko Lifesciences reported a net profit of 4.50 Cr in 2026.